BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1000517)

  • 1. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
    von Eyben FE; Larsen V; Pedersen H
    Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
    Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U
    Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG; Desai SA; DeWys WD
    Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
    Vogl SE; Qazi R; Berenzweig M
    Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea (FIVB) in colon cancer.
    Falkson G; Falkson HC
    Cancer Chemother Pharmacol; 1981; 6(1):31-4. PubMed ID: 7023714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in alimentary tract malignomas.
    Queisser W; Heim ME
    Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
    [No Abstract]   [Full Text] [Related]  

  • 15. [The state of chemotherapy of colorectal neoplasms].
    Hossfeld DK
    Z Gastroenterol Verh; 1978; (14):97-102. PubMed ID: 88849
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DTIC (NSC-45388) studies in the southwest oncology group.
    Costanzi JJ
    Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):45-8. PubMed ID: 6837506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies with DTIC (NSC-45388) in various malignancies.
    Slavik M
    Cancer Treat Rep; 1976 Feb; 60(2):213-4. PubMed ID: 769976
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.